Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions. by Munk, Marion et al.
Idiopathic multifocal choroiditis/punctate inner choroidopathy 
with acute photoreceptor loss or dysfunction out of proportion 
to clinically visible lesions
Marion R. Munk, MD, PhD1,2, Jesse J. Jung, MD3,4,5, Kristin Biggee, MD6, William R. 
Tucker, BMBS, BSc, FROph7, H. Nida Sen, MD, MHSc7, Ursula Schmidt-Erfurth, MD2, 
Amani A. Fawzi, MD1, and Lee M. Jampol, MD1
1Dept of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 
United States
2Department of Ophthalmology, Medical University Vienna, Vienna, Austria
3Department of Ophthalmology, New York University School of Medicine, New York, NY, United 
States
4Vitreous Retina Macula Consultants of New York, New York, NY, United States
5Department of Ophthalmology, Edward S. Harkness Eye Institute Columbia College of 
Physicians and Surgeons, New York, NY, United States
6Department of Ophthalmology, Casey Eye Institute/Oregon Health and Science, Portland, OR, 
United States
7National Eye Institute, National Institute of Health, Bethesda, MD, United States
Abstract
Purpose—To report acute/subacute vision loss and paracentral scotomata in patients with 
idiopathic multifocal choroiditis/punctate inner choroidopathy (MFC/PIC) due to large zones of 
acute photoreceptor attenuation surrounding the chorioretinal lesions.
Methods—Multimodal-imaging case-series
Results—Six females and 2 males were included (mean age 31.5±5.8 years). Vision ranged from 
20/20-1 to hand motion (mean 20/364). SD-OCT demonstrated extensive attenuation of the 
external limiting membrane (ELM), ellipsoid and interdigitation zones, adjacent to the visible 
MFC/PIC lesions. The corresponding areas were hyperautofluorescent on fundus-autofluorescence 
(FAF), and were associated with corresponding visual field defects. Full-field ERG (available in 3 
cases) showed markedly decreased cone/rod response and multifocal ERG revealed reduced 
amplitudes and increased implicit times in 2 cases. Three patients received no treatment, the 
remaining were treated with oral corticosteroids (n=4), oral acyclovir/valacyclovir (n=2), 
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intravitreal/posterior subtenon triamcinolone-acetate (n=3) and anti-VEGF (n=2). Visual recovery 
occurred in only 3 cases, of whom 2 were treated. Varying morphological recovery was found in 6 
cases, associated with decrease in hyperautofluorescence on FAF.
Conclusions—MFC/PIC can present with transient or permanent central photoreceptor 
attenuation/loss. This presentation is likely a variant of MFC/PIC with chorioretinal atrophy. 
Associated changes are best evaluated using multimodal imaging.
Keywords
Multifocal choroiditis; punctate inner choroidopathy; AZOOR; optical coherence tomography; 
acute visual function loss; autofluorescence; photoreceptor loss
Introduction
Idiopathic multifocal choroiditis (MFC) and punctate inner choroidopathy (PIC) are 
inflammatory disorders typically affecting young, myopic females with no associated 
systemic disease.1,2 Most of the current authors believe PIC, MFC and MFC and panuveitis 
represent the same underlying disease entity. 3,4 Although this is still controversial, they 
share the same cytokine polymorphism.5 With classic MFC/PIC, patients may note a 
decrease in visual acuity (VA) (dependent on the location of the chorioretinal lesions), 
floaters, photopsias and an enlarged blind spot.6 The vision loss is classically attributed to 
inflammation or choroidal neovascularisation (CNV). On examination MFC/PIC presents 
with yellow hazy (later punched out) lesions in the posterior pole or periphery; vitreous cells 
may be present.7 Our recent study described a variant of idiopathic MFC with concomitant 
zonal, multizonal or diffuse outer retinal or chorioretinal atrophy.8 In that study patients 
with discrete MFC lesions were found to have extensive outer retinal or chorioretinal 
atrophy which often progressed over time.8 Central vision was often spared or involved only 
late in the course. Previously some patients with MFC/PIC with disruption of the ellipsoid 
and interdigitation zones seen on SD-OCT in clinically uninvolved areas within macula have 
been described.3,9,10 In these cases, the outer retinal structures recovered and the hyper-
autofluorescence seen on fundus autofluorescence (FAF) faded with corticosteroid 
treatment.3,9,10
The aim of this current study is to describe the acute presentation of MFC/PIC with a 
dramatic decrease in visual acuity or central scotomata due to associated photoreceptor 
dysfunction out of proportion to the clinically visible lesions. In the described cases 
recovery from this insult was variable.
Methods
Patient selection and setting
This retrospective observational case series study included 8 patients (9 eyes) from 5 
referring institutions: Feinberg School of Medicine at Northwestern University in Chicago 
(Illinois), Vitreous Retina Macula Consultants of New York, Casey Eye Institute/Oregon 
Health and Science (Portland), National Eye Institute (National Institute of Health, 
Bethesda) and Medical University Vienna (Austria). The study adhered to the tenets of the 
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Declaration of Helsinki and was granted a waiver of informed consent by the Northwestern 
University institutional review board.
Patients diagnosed with idiopathic MFC or PIC with acute/subacute visual acuity loss or 
acute/subacute onset of central scotomata and photoreceptor-dysfunction adjacent to the 
lesions visible on SD-OCT were included. Patients with underlying associated systemic 
disease or possible infectious causes were excluded. Medical workup in individual cases 
varied but was uniformly negative for infectious or immune ocular or systemic diseases. 
Data collection in all patients included age, sex, medical history (medication and history of 
therapy), best corrected visual acuity (BCVA), refraction, slit-lamp examination and 
ophthalmoscopy. Multimodal image analysis included SD-OCT, Infrared (IR), Red-free, 
short-wave blue (488nm) fundus autofluorescence (FAF) (HRA+OCT Spectralis; 
Heidelberg Engineering, Heidelberg, Germany), green near-infrared (787nm)-FAF (Optos, 
Marlborough, MA, USA and/or Topcon America, Paramus, NJ, USA), fluorescein 
angiography (FA), indocyanine angiography (ICGA) (Heidelberg Engineering, Heidelberg, 
Germany or Topcon America, Paramus, NJ, USA), color fundus photographs (Topcon 
America, Paramus, NJ, USA) and/or wide field color fundus images (Optos, Marlborough, 
MA, USA). Additional functional analysis included a full-field electroretinogram (ffERG) in 
3 patients (case 2+5+7) and a multifocal (mf) ERG in 2 patients (case 1+2). One patient (2 
eyes) also had visual evoked potentials (VEP) and electrooculography (EOG) completed 
(case 7). Six out of 8 patients had a Humphrey visual field (HVF) performed, 1 had a 
Goldmann visual field (GVF) and 1 had microperimetry. Medical records were reviewed at 
presentation and during follow-up.
Results
Demographic characteristics and multimodal evaluation
Seven patients (8 eyes; 5 women and 2 men) were diagnosed with idiopathic MFC/PIC and 
visual acuity loss, and one patient (1 woman) was diagnosed with MFC/PIC and paracentral 
scotomata due to photoreceptor attenuation beyond the ophthalmoscopically visible lesions. 
No patient showed vitreous cells and/or vitreous haze. Demographic characteristics and 
treatment can be found in Table 1. Six patients were seen at initial onset and two patients 
were first seen years after their acute VA decrease. Mean age at disease onset was 31.5±5.8 
years. Mean age at initial presentation to us was 33.3±7.8 years.
Mean distance BCVA at baseline was 20/364 (1.26±0.75logMAR), ranging from the 
severity of hand motion (HM) to 20/20-1 (depending on the extent of foveal involvement of 
the photoreceptor loss/irregularity). Mean distance BCVA at the last follow up visit was 
20/252 (1.1±0.92logMAR, range from HM+ to 20/20-1) (Table 1). The mean duration of 
follow-up was 25±33months (range 3–82 months). Three of the patients eventually 
developed CNV during the observational period and 1 patient presented with an old 
extrafoveal scar suspicious for a previous active CNV. Three cases received no treatment, 
the remaining cases were treated with oral corticosteroids (n=4), oral acyclovir/valacyclovir 
(n=2), intravitreal/posterior subtenon triamcinolone-acetate (n=3) and anti-VEGF (n=2) 
(Table 1). Complete morphological and visual function recovery was found in 3 patients (1 
untreated, 2 treated with oral corticosteroids). Another three patients had some restoration of 
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the ELM and the ellipsoid zone, without visual functional recovery (2 treated with oral 
corticosteroids and intravitreal/posterior subtenon triamcinolone-acetate, 1 treated with 
intravitreal triamcinolone-acetate and bevacizumab). The remaining 2 cases by history 
displayed no recovery of the hyperreflective bands or visual function but these 2 patients 
were first seen by us years after initial onset of symptoms (both never received any 
treatment). No patient was documented to have new areas of PR-loss in SD-OCT during 
follow up. However, 3 cases (case 1+4 +7) showed increasing VF-defects over time. Visual 
acuity and imaging findings at baseline and during follow up are summarized in Table 1 and 
2.
Case reports
Case 1—A 24 year old Caucasian woman noted a black cloud OD for 5 days. An 
ophthalmologist detected chorioretinal lesions in the posterior pole with a BCVA of 20/125 
and started her on oral prednisone 75mg. Within 5 days her vision dropped to counting 
fingers (CF) and she was referred for evaluation. At presentation she was on 25mg 
prednisone and her BCVA was CF-/HM+ OD at 1m and 20/20 OS. The anterior chamber 
was quiet and there were no vitreous cells. Ophthalmoscopy revealed multiple chorioretinal 
lesions OD, at various stages of evolution; some old and pigmented others new with a 
creamy poorly circumscribed appearance (Figure 1A). Oral prednisone was increased to 
50mg, valacyclovir (2000 mg) was started and she briefly received oral clindamycin and co-
trimoxazole. An extensive work-up was negative. SD-OCT revealed subRPE lesions and 
extensive ELM-, ellipsoid and interdigitation zones -loss (Figure 1B). The disruption of 
these respective layers corresponded to hyporeflectivity on the IR image (Figure 1B). FAF 
showed diffuse hyperautofluorescence. Amsler grid, GVF and HVF revealed extensive 
central and peripheral visual field loss with a temporal island of preserved visual field. 
Pattern ERG demonstrated a significantly reduced P50 amplitude OD and mfERG revealed 
markedly reduced amplitudes sub- and parafoveally indicating a loss of macular visual 
function. FA showed late staining and late ICGA showed hypofluorescence corresponding 
to the visible lesions. Over the next two months, prednisone was slowly tapered. 
Valacyclovir was stopped after 4 weeks. Two months later, VA was 20/800 and SD-OCT 
showed incomplete recovery of the hyperreflective bands. The hyporeflectivity on IR 
remained (Figure 1C). At 4 months she experienced further VA decrease down to CF. New 
MFC/PIC lesions and old bridging scar tissue were seen (Figure 1D). Late FA images 
revealed some new leakage around the chorioretinal lesions (Figure 1E) and SD-OCT 
revealed further photoreceptor-loss. FAF demonstrated an increase in 
hyperautofluorescence. GVF revealed further constriction of the temporal visual field island. 
The patient was restarted on 50mg prednisone and received a posterior subtenon injection of 
triamcinolone acetate OD. Her BCVA increased slightly to 20/800. Oral Prednisone therapy 
was tapered over the next 5 months and then stopped. Despite some central visual function 
improvement and some morphological recovery of the photoreceptors on SD-OCT (Figure 
1F), the hyperautofluorescence on FAF (Figure 1G) remained and the GVF showed no 
recovery. Four months later, she presented again with a sudden onset of VA decrease down 
to CF- OD, however no new lesions were found. One month thereafter the patient presented 
with central CNV accompanied by subretinal fluid and intraretinal cysts. She was treated 
with a single intravitreal triamcinolone acetate injection (IVTA). Her BCVA returned to 
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20/600 and at the last follow-up visit the intraretinal cysts as well as subretinal fluid had 
almost completely resolved.
Case 2—A 34 year old Caucasian woman with moderate myopia (spherical equivalent 
(SE): −2.75) experienced monocular visual loss OD. Her symptoms first began with a small 
paracentral scotoma OD that progressed in density over the following year. Her VA during 
this time period was 20/20 OU (Figure 2A). Examination revealed creamy yellow round 
spots in her right macula that had increased in number over this year. Her left eye was 
unaffected except for one small yellow macular lesion. Her subjective scotoma faded over 
the next 6 months, but she then suddenly awoke with acute central vision loss and a visual 
acuity of HM in the right eye. Retinal examination revealed further increase in size and 
number of creamy yellow spots OD (Figure 2B). FA revealed staining of the chorioretinal 
lesions with some mild surrounding late leakage inferotemporally. There was a 
hypofluorescent lesion at the inferior arcade which did not leak but was suspicious for 
inactive CNV (Figure 2C). The day following her acute vision loss, she received a posterior 
subtenon triamcinolone acetate injection without subsequent visual improvement. Nine days 
later she presented for evaluation. Imaging was performed including blue short-wave 
(488nm) and green near infrared (787nm) FAF which was remarkable for a diffuse area of 
hyper-autofluorescence with mottled borders in the right macula and peripapillary area 
(Figure 2D). Her chorioretinal lesions corresponded to hypoautofluorescent spots on FAF. In 
addition to multiple outer chorioretinal lesions, SD-OCT showed extensive and diffuse 
ELM- and ellipsoid-/interdigitation zones loss and thinning of the RPE layer OD (Figure 
2E). The ffERG showed decreased amplitudes OU consistent with mild rod and cone 
dysfunction, worse OD. The mfERG revealed subnormal amplitudes and prolonged implicit 
times OD and was normal OS. The extensive work-up was negative. Although there was no 
evidence or clinical finding of a helminthic infection the patient was empirically treated for 
thirty days with oral albendazole. The patient was also started on oral prednisone 80mg daily 
for two weeks which was then slowly tapered over two months. Subsequent examinations 
and imaging over the following two months revealed no increase in vision, but a decrease in 
the number and size of chorioretinal spots and a decreased intensity of the fundus hyper-
autofluorescence (Figure 2F+G). OCT-imaging demonstrated minor recovery of the ELM, 
ellipsoid - and interdigitation zones (Figure 2H and I). At the last visit, 21 months after 
initial presentation, the patient’s vision was still HM OD.
Case 3—A 26 year old Caucasian woman with a scotoma and macular lesions OD for 1 
month was referred for evaluation. The patient described blurred vision and a paracentral 
scotoma after waking up accompanied by flashes and floaters in the right eye. Her medical 
history was negative. Her BCVA was 20/20 OU. Indirect ophthalmoscopy revealed 
peripapillary atrophy and MFC/PIC lesions superior to the fovea OD. SD-OCT showed a 
juxtafoveal choroidal lesion with choroidal excavation and demonstrated loss and 
irregularity of the ELM, ellipsoid- and interdigitation zones adjacent to the MFC/PIC lesion 
(Figure 3A). This photoreceptor-irregularity/loss corresponded to hyperautofluorescence on 
short wave blue (488nm) FAF (Figure 3A) and with hyporeflectivity on the IR. Follow-up 
visit 4 months later revealed improvement of the ELM, the ellipsoid and the interdigitation 
zones and the hyperautofluorescence and hyporeflectivity had decreased in intensity (Figure 
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3B). The BCVA was 20/20 OU and the patient reported a subjective improvement in her 
vision and fading of the paracentral scotoma. However, a small superotemporal scotoma 
remained which was delineated in the 24-2 HVF and which corresponded to a still 
attenuated but overall improved appearance of the ELM, ellipsoid and interdigitation zones. 
Two months thereafter this scotoma also had nearly vanished.
Case 4—A 38 year old Caucasian woman with myopia (SE: −3.25D OU) and a two year 
history of decreased visual function and metamorphopsia OS was referred for evaluation. 
She had been previously treated with 7 injections of intravitreal bevacizumab OS. At initial 
presentation her BCVA was 20/16 OD and 20/400 OS. No active CNV was identified. She 
had peripapillary atrophy with 2 large parafoveal chorioretinal lesions and 3 smaller lesions 
superior to the fovea (Figure 4A). FA demonstrated window defects adjacent to the disc and 
late staining of the hypofluorescent lesions (Figure 4B). On ICGA more chorioretinal lesions 
were identified compared to examination and FA (Figure 4C). Beside the chorioretinal 
lesions, a plaque of hypofluorescence on ICGA was noted in the early and in the late frames, 
which was in turn surrounded by a discrete hyperfluorescent ring. Blue short wave (488nm) 
- as well as near infrared (787nm) FAF revealed a paracentral and peripapillary 
hyperautofluorescence which corresponded to the hypofluorescent area on ICGA (Figure 
4D) and to a hyporeflective area on IR. SD-OCT changes (Figure 4E) displayed blurred and 
indistinct ellipsoid and interdigitation zones and a hyperreflective Henle’s layer. These areas 
corresponded to the FAF hyperautofluorescence, the ICGA hypofluorescence, the IR 
hyporeflectivity (Figure 3E) and to the VF defect (Figure 4F). The patient was treated with 
IVTA. One month later BCVA was 20/80. Although the hyperautofluorescence had 
decreased in intensity and the photoreceptor status had improved, the VF defect and the 
absolute scotomata on microperimetry had increased in size (Figure 4G+H). Four months 
after IVTA and initial presentation to us BCVA worsened again to 20/160 and CNV was 
suspected. The patient was treated again with IVTA and intravitreal bevacizumab. Central 
vision improved, but the microperimetry again revealed an increase in absolute scotomata 
(Figure 4H). As intraocular pressure (IOP) pressure was not controllable with topical 
medications a tube shunt surgery was performed 5 month after initial presentation. At the 
last visit the BCVA was 20/125 OS and IOP was 14. Despite improvement of the ellipsoid 
and the interdigitation zones, resolution of the hypofluorescent plaque on ICGA and further 
decrease of the FAF hyperautofluorescence, the scotomata seen with microperimetry and 
visual field defects continued to enlarge (Figure 4H+4I). It remains unclear whether the 
increased IOP contributed to the increase in VF defects.
Discussion
These 8 patients diagnosed with MFC/PIC presented with an acute/subacute onset of 
decreased visual acuity and scotomata with vision loss as severe as CF- and HM+. This 
decrease in visual acuity and visual field loss was secondary to central photoreceptor 
attenuation. These changes involved retina adjacent to the clinically visible lesions as well 
as other locations. As far as evaluable (limited to the extension of the SD-OCT scans) the 
photoreceptor irregularity corresponded to hyperautofluorescence on FAF and scotomata on 
VF testing. In addition the areas of photoreceptor attenuation corresponded to 
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hyporeflectivity on IR imaging in 3 cases and ICGA hypofluorescence in 1 case. In contrast 
to previous reports, which described a transient decrease in VA with concomitant temporary 
photoreceptor attenuation in MFC/PIC followed by complete recovery, 3,9–11 we 
demonstrate that severe, persistent visual function loss can occur. The spectrum of the 
clinical course in our patients ranged from total visual recovery and concomitant restoration 
of the outer retinal layers and decrease in hyperautofluorescence without any treatment to 
persistent severe visual function loss despite maximal and immediate therapy.
Idiopathic MFC/PIC may be an immune mediated disease occurring in genetically 
susceptible individuals.2,5 Previous reports have noted MFC/PIC with photoreceptor 
attenuation beyond the chorioretinal lesions or have described MFC/PIC accompanied by 
enlarged blind spots.9–11,13–18 Some authors have described this MFC/PIC variant as part of 
the AZOOR complex.13,14,19 The original Gass case series, which first described AZOOR, 
included patients with MFC lesions.20 Spaide et al. reported 11 patients with MFC and blind 
spot enlargement and found that the scotomata correlated with the loss of the photoreceptor 
outer segments on SD-OCT.16 Chen et al. reported in their series of PIC patients that the 
scotomata seen in these patients also corresponded to the photoreceptor-loss visible on SD-
OCT.10 Kramer et al. found that these areas of photoreceptor-loss in patients with MFC 
corresponded to hyperautofluorescence, which was also verified by reports from Jung et al. 
and Freund et al.9,11,12 All these findings are consistent with our observations. The 
underlying cause of the hyperautofluorescence in areas of photoreceptor attenuation 
associated with MFC/PIC remains unclear. Hyperautofluorescence may be due to active 
inflammation in this disease entity. 9,11,12 It may be secondary to increased accumulation of 
fluorophores within the RPE due to inflammation 21 or caused by a reduction of the optical 
pigment density due to disruption of the photoreceptors.12,22,23 The cause of the plaque-like 
hypofluorescence on ICGA, previously reported in MFC remains also uncertain. 9, 17 
Choroidal hypo-perfusion, choroidal ischemia or a blockage-effect were assumed to cause 
this finding.17, 24–26 Hyperreflectivity in the Henle’s layer corresponding to the 
hypofluorescent area in this case and the fact that increased choroidal thickness is found in 
areas corresponding to the photoreceptor irregularity in MFC/PIC with secondary 
photoreceptor loss in the acute inflammatory stage,10 made us believe that a blockage effect 
rather than choroidal hypo-perfusion is responsible for the hypofluorescence on ICGA found 
in our patient.
During follow-up the FAF hyper-autofluorescence, the ICGA hypofluorescence as well as 
the IR hyporeflectivity faded corresponding to the restoration of the ELM, the ellipsoid- and 
interdigitation zones. This correlates with previous published observations.9,11,17 However, 
in previous reports the photoreceptor-attenuation and hyperautofluorescence resolved 
completely under immune modulating therapy and BCVA returned back to normal.3,9,10 In 
our series, BCVA fully recovered only in 3 out of 8 cases. The remaining patients displayed 
persistent decreased BCVA and photoreceptor attenuation. A recent report by our group 
described a variant of MFC with significant outer retinal and or chorioretinal atrophy. This 
atrophy often progressed over time despite therapy.8 In contrast to the current observations, 
in these patients foveal sparing was common until late in the disease course and the majority 
of the patients maintained good VA.8 In our cohort, 3 cases (case 3, 6 and 8) recovered 
similar to the reports of Kramer et al., Spaide et al. and Chen et al., 3,10,11 two while 
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undergoing systemic corticosteroid and anti-VEGF treatment and one patient recovered 
without treatment and retained a very small discrete relative paracentral scotoma. Two of 
our cases (case 5+7) presented with already existing central vision- and corresponding 
photoreceptor loss and with extinguished or diminished cone and rod response on ERG 
testing. The remaining 3 cases (case 1, 2+4) displayed persistent decrease in VA despite 
immediate treatment. We believe that the patients presented here represent a MFC/PIC 
variant with adjacent photoreceptor-attenuation. MFC/PIC with adjacent photoreceptor 
attenuation may vary in severity and may lead to chorioretinal atrophic lesions,11 acute 
persistent central photoreceptor loss and outer retinal atrophy, diffuse peripheral or zonal 
outer retinal and chorioretinal atrophy, 8 or to transient photoreceptor attenuation with 
recovery of morphology and function.3,10 Depending on the severity of the process, changes 
may be self-limiting and/or apparently respond to immune modulating therapy. In some 
cases, the acute photoreceptor attenuation may be permanent. The exact mechanisms 
involved in the outer retinal dysfunction and death remain unclear and no obvious factors 
indicating severity or permanence of photoreceptor loss was identifiable. The only 
parameter noteworthy may be that patients, who developed new lesions over time (case 1, 2 
and 7) showed the worst VA outcome.
Interestingly, 3 cases (case 1, 2 and 4) with persistent decrease in VA showed some 
anatomical recovery of the outer retinal layers. In these cases the ELM and ellipsoid zone 
showed some restoration, however the interdigitation zone remained non-distinguishable. 
This picture may resemble re-integration of the inner segments with persistently damaged 
cone outer segments, which may explain the permanent visual function loss despite the 
partial recovery of the 1st and 2nd hyperreflective band. In order to solve the apparent 
discrepancy between morphology and function, imaging approaches such as adaptive optics 
scanning laser ophthalmoscopy (AO-SLO), AO-OCT or AO using split detection are 
warranted, to precisely illustrate the status of the photoreceptors.
The efficacy of treatment for this presentation of MFC/PIC is uncertain: Spaide et al. as well 
as Chen et al. and Kramer et al. noted an improvement after treatment initiation and 
therefore stated that immune modulating therapy induced respective recovery.3,9,10 In 
contrast, Jung et al. reported progression of outer retinal atrophy in the variant of MFC with 
outer retinal and chorioretinal atrophy in some patients despite systemic immune-
modulating therapy.8 Five out of the 8 patients in our cohort were treated, but only two 
regained their visual function after treatment initiation. Although some studies have reported 
that immunomodulatory therapy of MFC/PIC can effectively control inflammation, 27 other 
studies have shown that the inflammation can be difficult to control.28 Although some cases 
of idiopathic MFC with secondary acute photoreceptor loss can be self-limiting it is worth 
considering immune modulating treatment, especially in progressive cases that develop new 
chorioretinal lesions over time. However, this therapy may not result in recovery.
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Summary statement
Idiopathic multifocal choroiditis/punctate inner choroidopathy can present with acute 
central outer photoreceptor disruption associated with decreased vision and visual field 
defects. Multimodal imaging highlights the acute damage seen in this disease process.
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Figure 1. Case 1
Optomap (A) of the right eye reveals pigmented multifocal choroiditis (MFC) lesions in the 
inferotemporal periphery. Centrally there are several new creamy chorioretinal lesions 
inferior to the fovea. Spectral-domain optical coherence tomography (SD-OCT) (B) has 
extensive photoreceptor loss/irregularity: the central cross-section scan demonstrates 
extensive loss of the external limiting membrane (ELM), ellipsoid- and interdigitation zones, 
more pronounced temporally. The SD-OCT through active chorioretinal lesions highlights 
adjacent loss of the respective layers. On infrared (IR) a hyporeflective area is noted which 
corresponds to the photoreceptor disruption on SD-OCT (yellow arrow). Follow-up 2 
months later shows some recovery of the photoreceptors: SD-OCT (C) outlines some 
regeneration of the ELM, ellipsoid and interdigitation zones. The hyporeflective IR area 
remained (yellow arrow). 6 months from baseline: The late indocyanine angiography 
(ICGA) (D) reveals new hypofluorescent lesions. Fluorescein angiography (FA) image (E) 
shows new, hyperfluorescent multifocal lesions that leak in the late phase. 12 months after 
initial presentation: SD-OCT (F) shows that the chorioretinal hyperreflective nodules 
representing MFC lesions have grown in size. Although the interdigitation zone is still not 
well defined the ellipsoid zone shows further recovery and is now distinguishable. 
Hyperautofluorescence (near infrared 788nm fundus autofluorescence) (G) is still visible, 
but could be also due to a photobleaching effect.
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Figure 2. Case 2
Color fundus image (A) of the right eye reveals yellowish circumscribed chorioretinal 
lesions temporal to the fovea. Best corrected visual acuity (BCVA) was 20/20 One year later 
the patient presents with sudden visual acuity loss down to hand motion (HM) (B): There is 
a visible increase in the size and number of yellowish creamy chorioretinal lesions within 
the macula. Fluorescein angiography (FA) (C) shows staining and some mild late leakage. 
The inferotemporal hypofluorescent lesion is surrounded by a subtle hyperfluorescent ring 
suspicious for a possible inactive choroidal neovascular membrane. Near infrared (787nm) 
(D) fundus autofluorescence (FAF) is remarkable for a distinctive area of 
hyperautofluorescence throughout the posterior pole. The spectral domain optical coherence 
tomography (SD-OCT) scan (E) has extensive loss of the external limiting membrane 
(ELM), ellipsoid and interdigitation zones. The retinal pigment epithelium is thinner and 
less reflective. Near infrared (787nm) FAF (F+G) highlights the decrease in hyper-
autofluorescence over the next two months. The chorioretinal lesions corresponding to 
hypoautofluorescent spots on FAF have decreased in number as well as in size. 
Correspondingly, SD-OCT (H+I) shows partial restoration of the ELM and ellipsoid zones. 
Hereby the respective bands remain attenuated and less hyperreflective and the 
photoreceptor-complex and the outer nuclear layer appears significantly thinner when 
compared to the non-affected fellow eye. The interdigitation zone is not distinguishable. The 
BCVA remains HM.
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Figure 3. Case 3
3A: Top: Spectral domain optical coherence tomography (SD-OCT) outlines the 
chorioretinal lesion presenting as a hyperreflective deposit which has broken through the 
RPE disrupting the overlying retina. The adjacent external limiting membrane (ELM), 
ellipsoid and interdigitation zones are not distinguishable. Middle: Fundus autofluorescence 
reveals hyperautofluorescence and the central macular scan shows a relative sparing of the 
fovea. Bottom: SD-OCT B-scan superior to the lesion verifies the adjacent loss of the ELM, 
the ellipsoid- and interdigitation zone.
3B: Follow-up at 4 months: Recovery of the hyperreflective bands on SD-OCT can be 
observed. Compared to the left eye, however, the ELM, ellipsoid and interdigitation zones 
still appear partially disrupted. Middle: Autofluorescence reveals a decrease in 
hyperautofluorescence
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Figure 4. Case 4
Color photographs of the left eye (A) reveals peripapillary atrophy, 2 large yellow 
parafoveal chorioretinal lesions and 3 smaller lesions superior to the fovea. Fluorescein 
angiography (FA) (B) identifies window defects and late staining of the chorioretinal 
lesions. Indocyanine green angiography (ICGA) highlights (C) the hypofluorescent lesions 
but also has a plaque-like hypofluorescent area which corresponds to the hyper-
autofluorescent area seen with near infrared- (787nm) autofluorescence (FAF) (D): Near 
infrared-FAF outlines the clear ring-shaped hyperautofluorescence visible around the optic 
disc and around the fovea. Corresponding spectral domain optical coherence tomography 
(SD-OCT) changes (E) include an indistinct external limiting membrane (ELM), ellipsoid 
and interdigitation zones adjacent to the chorioretinal lesions and a hyperreflective Henle’s 
layer, which seems to correspond to the hypofluorescence on ICGA (red arrows). 
Corresponding to the hyperreflectivity in the Henle’s layer, the hyperreflectivity of the 
ELM, ellipsoid and interdigitation zones is further attenuated (red arrows). There is also 
hyporeflectivity on the IR imaging visible (yellow arrows) corresponding to the 
hypofluorescence on ICGA and the hyperautofluorescence with near infrared FAF. The 
visual field (F) defect corresponds to the area of hyperautofluorescence. Two months later: 
The hyperautofluorescence has decreased in intensity but the visual field defect (G) as well 
as the central scotoma (H) has increased in size. Five months later: The hypofluorescence on 
ICGA has faded (I) but the absolute scotoma has continuously grown in size (H)
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